Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Cardiovascular

This is a picture of anatomical heart to go along with MassDevice's cardiovascular device news home, courtesy of Kenny Eliason on Unsplash.Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.

🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation

Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):

+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know

Latest Cardiology News

FDA panel thumbs down on CardioMEMS implantable heart monitor

By Leave a Comment

CardioMEMS
St. Jude Medical

An FDA advisory panel decided that CardioMEMS failed to prove that its wireless, implantable heart monitor’s benefits outweigh its risks, casting a shadow on a potential $375 million acquisition by St. Jude Medical (NYSE:STJ) – which already owns nearly a fifth of CardioMEMS.

Bard to cut 50 jobs

By Leave a Comment

bard

C.R. Bard Inc. (NYSE:BCR) plans to cut 50 jobs from its Queensbury, N.Y.-based manufacturing plant.

The 50 positions could be relocated outside the U.S., according to the Glen Falls, N.Y.-based Post Star. That would leave the Queensbury plant with roughly 770 employees.

MassDevice.com +3 | FDA releases artificial pancreas guidance, Study reinforces stent crumpling concern and Med-tech for paralysis patients wins key radio spectrum

By Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

MassDevice.com +3 | Bovie questions COO’s credentials, St. Jude announces FDA win amid Riata lead concerns and Histogen wins patent battle against SkinMedica

By Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

BSX offers 10 year warranties on newly cleared defibrillators | Regulatory Roundup

By Leave a Comment

Boston Scientific's Incepta, Energen and Punctua ICDs

Incepta, Energen and Punctua

Boston Scientific Corp. (NYSE:BSX) landed FDA clearance for its Incepta, Energen and Punctua cardiac implants to treat heart failure and sudden cardiac death.

To go along with the new defibrillator systems, the Natick, Mass.-based med-tech titan is providing an extended warranty for the Incepta and Energen family of defibrillators.

St. Jude lands FDA win for quadripolar pacing, warns docs on Riata leads

By Leave a Comment

St. Jude logo

St. Jude Medical Inc. (NYSE:STJ) sported some good news and some bad news, touting a regulatory win for its novel quadripolar pacing system while also warning doctors that its Riata defibrillator leads may pose a greater risk than previously reported.

The St. Paul, Minn.-based med-tech titan announced FDA clearance for the Unify Quadra cardiac resynchronization therapy defibrillator and Quartet left ventricular quadripolar pacing lead, calling it an industry first.

St. Jude touts industry first with U.S. clearance of quadripolar pacing system

By Leave a Comment

ST. PAUL, Minn., Nov 29, 2011 (BUSINESS WIRE) — St. Jude Medical, Inc. STJ +6.19% , a global medical device company, today announced it has received U.S. Food and Drug Administration (FDA) approval of its Unify Quadra(R) cardiac resynchronization therapy defibrillator (CRT-D) and Quartet(R) Left Ventricular Quadripolar Pacing Lead. The company will begin shipping the products to its sales force to begin providing to customers immediately.

Texas doc nearly clear of over-stenting charges | Legal News

By Leave a Comment

Dr. Samuel DeMaio

Dr. Samuel DeMaio

A Texas doctor accused of unnecessary stenting has slipped three of four trials against him with his license to practice in the Lone Star State intact.

Dr. Samuel DeMaio, accused last year of standard-of-care violations related to nine patients who allegedly received un-needed stents, angiograms and ICD implants, had pushed for a trial after mediation efforts with the Texas Medical Board collapsed.